TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy
Aim: We evaluated a novel approach combining the use of attenuated Salmonella immunotherapy with a Toll-like receptor agonist, imiquimod, in B16F1 melanoma-bearing mice. Materials & methods: B16F1 melanoma-bearing mice were daily treated with topical imiquimod in combination with one intratumoral in...
Kaydedildi:
| Yazar: | |
|---|---|
| Diğer Yazarlar: | , , , , , |
| Materyal Türü: | article |
| Dil: | İngilizce |
| Baskı/Yayın Bilgisi: |
2018
|
| Konular: | |
| Online Erişim: | https://hdl.handle.net/20.500.12008/42097 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|
| _version_ | 1868890136891097088 |
|---|---|
| author | Vola, Magdalena |
| author2 | Monaco, Amy Bascuas, Thais Rimsky, Geraldine Agorio, Caroline Isabel Chabalgoity, José Alejandro Moreno, María |
| author2_role | author author author author author author |
| author_browse | Agorio, Caroline Isabel Bascuas, Thais Chabalgoity, José Alejandro Monaco, Amy Moreno, María Rimsky, Geraldine Vola, Magdalena |
| author_facet | Vola, Magdalena Monaco, Amy Bascuas, Thais Rimsky, Geraldine Agorio, Caroline Isabel Chabalgoity, José Alejandro Moreno, María |
| author_role | author |
| collection | COLIBRI |
| dc.contributor.none.fl_str_mv | Vola Magdalena, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico Monaco Amy, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico Bascuas Thais, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico Rimsky Geraldine, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico Agorio Caroline Isabel, Universidad de la República (Uruguay). Facultad de Medicina. Hospital del Clínicas. Cátedra de Dermatología Chabalgoity José Alejandro, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico Moreno María, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico |
| dc.creator.none.fl_str_mv | Vola, Magdalena Monaco, Amy Bascuas, Thais Rimsky, Geraldine Agorio, Caroline Isabel Chabalgoity, José Alejandro Moreno, María |
| dc.date.none.fl_str_mv | 2018 2024-01-03T13:16:09Z 2024-01-03T13:16:09Z |
| dc.format.none.fl_str_mv | application/pdf |
| dc.identifier.none.fl_str_mv | VOLA, M., MÓNACO, A., BASCUAS, T., y otros. TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy. Immunotherapy [en línea] 2018, 10(8), 665-679. DOI: 10.2217/imt-2017-0188. https://hdl.handle.net/20.500.12008/42097 10.2217/imt-2017-0188 |
| dc.language.none.fl_str_mv | en eng |
| dc.relation.none.fl_str_mv | Immunotherapy. 2018, 10(8) |
| dc.rights.none.fl_str_mv | info:eu-repo/semantics/openAccess Licencia Creative Commons Atribución (CC - By 4.0) |
| dc.source.none.fl_str_mv | reponame:COLIBRI instname:Universidad de la República instacron:Universidad de la República |
| dc.subject.none.fl_str_mv | Experimental model Imiquimod Immunotherapy Melanoma Salmonella |
| dc.title.none.fl_str_mv | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| dc.type.none.fl_str_mv | Artículo info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
| description | Aim: We evaluated a novel approach combining the use of attenuated Salmonella immunotherapy with a Toll-like receptor agonist, imiquimod, in B16F1 melanoma-bearing mice. Materials & methods: B16F1 melanoma-bearing mice were daily treated with topical imiquimod in combination with one intratumoral injection of attenuated Salmonella enterica serovar Typhimurium LVR01. Results: The combined therapy resulted in retarded tumor growth and prolonged survival. Combination treatment led to an enhancement in the expression of pro-inflammatory cytokines and chemokines in the tumor microenvironment, with a Th1-skewed profile, resulting in a broad antitumor response. The induced immunity was effective in controlling the occurrence of metastasis. Conclusion: Salmonella LVR01 immunotherapy in combination with imiquimod is a novel approach that could be considered as an effective antimelanoma therapy. |
| eu_rights_str_mv | openAccess |
| format | article |
| id | anni_92e48fc656755d4950f3f8ed5d3eb9bf |
| identifier_str_mv | VOLA, M., MÓNACO, A., BASCUAS, T., y otros. TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy. Immunotherapy [en línea] 2018, 10(8), 665-679. DOI: 10.2217/imt-2017-0188. 10.2217/imt-2017-0188 |
| instacron_str | Universidad de la República |
| institution | Universidad de la República |
| instname_str | Universidad de la República |
| language | eng |
| language_invalid_str_mv | en |
| network_acronym_str | anni |
| network_name_str | oai-lr-anni |
| oai_identifier_str | oai:colibri.udelar.edu.uy:20.500.12008/42097 |
| publishDate | 2018 |
| publishDateSort | 2018 |
| reponame_str | COLIBRI |
| repository.mail.fl_str_mv | |
| repository.name.fl_str_mv | |
| repository_id_str | |
| rights_invalid_str_mv | Licencia Creative Commons Atribución (CC - By 4.0) |
| spelling | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapyVola, MagdalenaMonaco, AmyBascuas, ThaisRimsky, GeraldineAgorio, Caroline IsabelChabalgoity, José AlejandroMoreno, MaríaExperimental modelImiquimodImmunotherapyMelanomaSalmonellaAim: We evaluated a novel approach combining the use of attenuated Salmonella immunotherapy with a Toll-like receptor agonist, imiquimod, in B16F1 melanoma-bearing mice. Materials & methods: B16F1 melanoma-bearing mice were daily treated with topical imiquimod in combination with one intratumoral injection of attenuated Salmonella enterica serovar Typhimurium LVR01. Results: The combined therapy resulted in retarded tumor growth and prolonged survival. Combination treatment led to an enhancement in the expression of pro-inflammatory cytokines and chemokines in the tumor microenvironment, with a Th1-skewed profile, resulting in a broad antitumor response. The induced immunity was effective in controlling the occurrence of metastasis. Conclusion: Salmonella LVR01 immunotherapy in combination with imiquimod is a novel approach that could be considered as an effective antimelanoma therapy.Vola Magdalena, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo BiotecnológicoMonaco Amy, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo BiotecnológicoBascuas Thais, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo BiotecnológicoRimsky Geraldine, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo BiotecnológicoAgorio Caroline Isabel, Universidad de la República (Uruguay). Facultad de Medicina. Hospital del Clínicas. Cátedra de DermatologíaChabalgoity José Alejandro, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo BiotecnológicoMoreno María, Universidad de la República (Uruguay). Facultad de Medicina. Instituto de Higiene. Unidad Académica Desarrollo Biotecnológico2024-01-03T13:16:09Z2024-01-03T13:16:09Z2018Artículoinfo:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfVOLA, M., MÓNACO, A., BASCUAS, T., y otros. TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy. Immunotherapy [en línea] 2018, 10(8), 665-679. DOI: 10.2217/imt-2017-0188.https://hdl.handle.net/20.500.12008/4209710.2217/imt-2017-0188reponame:COLIBRIinstname:Universidad de la Repúblicainstacron:Universidad de la RepúblicaenengImmunotherapy. 2018, 10(8)Las obras depositadas en el Repositorio se rigen por la Ordenanza de los Derechos de la Propiedad Intelectual de la Universidad de la República.(Res. Nº 91 de C.D.C. de 8/III/1994 – D.O. 7/IV/1994) y por la Ordenanza del Repositorio Abierto de la Universidad de la República (Res. Nº 16 de C.D.C. de 07/10/2014)info:eu-repo/semantics/openAccessLicencia Creative Commons Atribución (CC - By 4.0)oai:colibri.udelar.edu.uy:20.500.12008/420972026-04-14T10:36:56Z |
| spellingShingle | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy Vola, Magdalena Experimental model Imiquimod Immunotherapy Melanoma Salmonella |
| status_str | publishedVersion |
| title | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| title_full | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| title_fullStr | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| title_full_unstemmed | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| title_short | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| title_sort | TLR7 agonist in combination with Salmonella as an effective antimelanoma immunotherapy |
| topic | Experimental model Imiquimod Immunotherapy Melanoma Salmonella |
| url | https://hdl.handle.net/20.500.12008/42097 |